MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

11 Feb 2022 Evaluate
Net sales declined -23.77%  to  Rs. 186.04 million from Rs. 244.04 millions.The Company's Net profit for the December 2021 quarter have declined marginally to Rs. 71.21  millions as against Rs. 74.70 millions reported during the corresponding quarter ended.The company reported a degrowth in operating Profit to 104.89 millions from 113.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 186.04 244.04 -23.77 860.91 672.65 27.99 905.63 851.24 6.39
Other Income 6.93 6.60 5.00 25.41 24.71 2.83 32.67 17.04 91.73
PBIDT 104.89 113.50 -7.59 475.06 344.95 37.72 435.95 335.42 29.97
Interest 3.27 1.71 91.23 6.49 6.89 -5.81 9.81 9.23 6.28
PBDT 101.62 111.79 -9.10 468.57 338.06 38.61 426.14 326.19 30.64
Depreciation 5.71 3.81 49.87 16.89 10.61 59.19 17.33 13.62 27.24
PBT 95.91 107.98 -11.18 451.68 327.45 37.94 408.81 312.57 30.79
TAX 24.70 33.28 -25.78 113.33 83.58 35.59 107.02 75.82 41.15
Deferred Tax 0.34 0.28 21.43 0.10 0.58 -82.76 1.26 -0.54 -333.33
PAT 71.21 74.70 -4.67 338.35 243.87 38.74 301.79 236.75 27.47
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 56.38 46.51 21.23 55.18 51.28 7.60 48.14 39.40 22.17
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..